Michael Catelani, ITUS Corp's COO & CFO, recently acquired 1,634 shares of the company. The buys took place at $1.84 per share, on April 30, 2021. Catelani now owns 9,383 shares of the company. Catelani operates out of San Jose,, CA. Some additional info was provided as follows:
The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to volun tarily report the acquisition of the shares.
In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on November 2, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ITUS Corp makes a similar move, sign up!
Other recent filings from the company include the following:
ITUS Corp Just Filed Its Quarterly Report: 6. NET LOSS PER SHAR... - June 10, 2021
General statement of acquisition of beneficial ownership - June 10, 2021
ITUS Corp's COO & CFO was just granted 200,000 options - June 2, 2021
ITUS Corp director was just granted 30,000 options - June 2, 2021
ITUS Corp's Chief Executive Officer was just granted 2,500,000 options and restricted shares - June 2, 2021